Microbiology & Virology
Read More about this categoryShow Less
Microbiology & Virology
A virus is a small infectious agent that replicates inside living cells. Viruses cause many human diseases from small illnesses, like influenza, to more deadly diseases, like hepatitis B and HIV. Our body’s immune system defends against viral infection by generating specific antibodies to bind to and neutralize viral particles and by cell mediated immunity that destroys infected host cells.
Research Areas
- Antibiotic(663)
- CCR5(2)
- CMV(29)
- gp120/CD4(4)
- HBV(92)
- HCV(146)
- HIV(414)
- HSV(103)
- Influenza virus(153)
- NA(7)
- Reverse Transcriptase(71)
- RSV(41)
- SRPK(6)
- SARS-CoV(186)
- Antifungal(46)
- Orthopoxvirus(4)
- Antimalaria(6)
- Beta-Lactamase(3)
- VEEV(1)
- Arenavirus(11)
- Bacterial(1568)
- Enterovirus(27)
- Filovirus(15)
- Fungal(427)
- Parasite(442)
- Virus Protease(77)
- Chicken Pox & Shingles(1)
- Chikungunya(1)
- Coronaviruses(34)
- Dengue(5)
- DNA & RNA Polymerase Inhibitors(10)
- Entry/Fusion Inhibitors(9)
- Epstein-Barr(1)
- Integrase Inhibitors(5)
- MERS(10)
- Rhinoviruses(3)
- West Nile Virus(1)
- Yellow Fever(2)
- Zika(2)
- COVID-19(41)
- Antiviral(2)
- Measles Virus(1)
Products Related to Microbiology & Virology(3916)
- GC72402VilobelimabCAS: 2250440-41-4Purity: >99.00%
Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5a antibody to the allergen C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction.
- GC72404TixagevimabCAS: 2420564-02-7Purity: 95.00%
Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD).
- GC72405RaxibacumabCAS: 565451-13-0Purity: >98.00%
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA).
- GC72409SuvratoxumabCAS: 1629620-18-3Purity: >98.00%
Suvratoxumab (MEDI4893) is a long-acting, high-affinity human anti-α-toxin monoclonal antibody (IgG1κ type).
- GC72412CilgavimabCAS: 2420563-99-9Purity: 95.00%
Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab .
- GC72421LarcaviximabCAS: 1792982-56-9Purity: >96.00%
Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody.
- GC72425MaftivimabCAS: 2135632-36-7Purity: >96.00%
Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent.
- GC72434OdesivimabCAS: 2135632-30-1Purity: >99.00%
Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein.
- GC72436PorgaviximabCAS: 1792982-55-8Purity: 98.00%
Porgaviximab is a monoclonal antibody that can be used Ebola infection research.
- GC72442QuisovalimabCAS: 2427667-03-4Purity: >96.00%
Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19.
- GC72446CosfroviximabCAS: 1792982-57-0Purity: 95.00%
Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP).
- GC72460RomlusevimabCAS: 2509447-08-7Purity: 95.00%
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
- GC72470ElipovimabCAS: 2101210-43-7Purity: >97.00%
Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cellsReferences:.
- GC72480Stilbamidine dihydrochlorideCAS: 6935-63-3Purity: >95.00%
Stilbamidine dihydrochloride is a diamidine compound derived from Stilbene and used chiefly in the form of its crystalline isethionate salt in treating various fungal infections.
- GC72510TbPTR1 inhibitor 2CAS: 17557-67-4Purity: >99.00%
TbPTR1 inhibitor 2 (Compound 3a) is a PTR1 enzyme inhibitor, with IC50s of 34.2 and 32.9 μM for TbPTR1 and LmPTR1.
- GC72515Methylisothiazolinone-d3 hydrochlorideCAS: 1329509-49-0
Methylisothiazolinone-d3 (hydrochloride) is the deuterium labeled Methylisothiazolinone (hydrochloride).
- GC725212-ChloroacetamideCAS: 79-07-2Purity: >98.00%
2-Chloroacetamide is a preservative and is a herbicide for both uplands and paddy fields.
- GC72542N4-Acetylsulfamethoxazole-d4CAS: 1215530-54-3
N4-Acetylsulfamethoxazole-d4 is the deuterium labeled N4-Acetylsulfamethoxazole.
- GC72550Fmoc-Pro-OH-13C5,15NCAS: 1217452-48-6
Fmoc-Pro-OH-13C5,15N is a 15N-labeled and 13C-labled Pyrimethanil.
- GC72584Benzisothiazolinone-13C5CAS: 1329616-16-1
Benzisothiazolinone-13C5 (1,2-Benzothiazol-3-one-13C5) is a 13C-labeled Benzisothiazolinone.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC72402 | Vilobelimab | 2250440-41-4 | >99.00% | |
Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5a antibody to the allergen C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. | ||||
| GC72404 | Tixagevimab | 2420564-02-7 | 95.00% | |
Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). | ||||
| GC72405 | Raxibacumab | 565451-13-0 | >98.00% | |
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). | ||||
| GC72409 | Suvratoxumab | 1629620-18-3 | >98.00% | |
Suvratoxumab (MEDI4893) is a long-acting, high-affinity human anti-α-toxin monoclonal antibody (IgG1κ type). | ||||
| GC72412 | Cilgavimab | 2420563-99-9 | 95.00% | |
Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab . | ||||
| GC72414 | Firivumab | 1443004-15-6 | 95.00% | |
Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. | ||||
| GC72421 | Larcaviximab | 1792982-56-9 | >96.00% | |
Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody. | ||||
| GC72425 | Maftivimab | 2135632-36-7 | >96.00% | |
Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent. | ||||
| GC72432 | Navivumab | 1443004-16-7 | >99.00% | |
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2. | ||||
| GC72434 | Odesivimab | 2135632-30-1 | >99.00% | |
Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. | ||||
| GC72436 | Porgaviximab | 1792982-55-8 | 98.00% | |
Porgaviximab is a monoclonal antibody that can be used Ebola infection research. | ||||
| GC72442 | Quisovalimab | 2427667-03-4 | >96.00% | |
Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. | ||||
| GC72446 | Cosfroviximab | 1792982-57-0 | 95.00% | |
Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP). | ||||
| GC72450 | Diridavumab | 1393659-46-5 | - | |
Diridavumab is a monoclonal anti-HA stalk antibody. | ||||
| GC72460 | Romlusevimab | 2509447-08-7 | 95.00% | |
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). | ||||
| GC72470 | Elipovimab | 2101210-43-7 | >97.00% | |
Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cellsReferences:. | ||||
| GC72480 | Stilbamidine dihydrochloride | 6935-63-3 | >95.00% | |
Stilbamidine dihydrochloride is a diamidine compound derived from Stilbene and used chiefly in the form of its crystalline isethionate salt in treating various fungal infections. | ||||
| GC72496 | Skatole-d8 | 697807-03-7 | >98.50% | |
Skatole-d8 is the deuterium labeled Skatole. | ||||
| GC72510 | TbPTR1 inhibitor 2 | 17557-67-4 | >99.00% | |
TbPTR1 inhibitor 2 (Compound 3a) is a PTR1 enzyme inhibitor, with IC50s of 34.2 and 32.9 μM for TbPTR1 and LmPTR1. | ||||
| GC72515 | Methylisothiazolinone-d3 hydrochloride | 1329509-49-0 | - | |
Methylisothiazolinone-d3 (hydrochloride) is the deuterium labeled Methylisothiazolinone (hydrochloride). | ||||
| GC72521 | 2-Chloroacetamide | 79-07-2 | >98.00% | |
2-Chloroacetamide is a preservative and is a herbicide for both uplands and paddy fields. | ||||
| GC72542 | N4-Acetylsulfamethoxazole-d4 | 1215530-54-3 | - | |
N4-Acetylsulfamethoxazole-d4 is the deuterium labeled N4-Acetylsulfamethoxazole. | ||||
| GC72550 | Fmoc-Pro-OH-13C5,15N | 1217452-48-6 | - | |
Fmoc-Pro-OH-13C5,15N is a 15N-labeled and 13C-labled Pyrimethanil. | ||||
| GC72584 | Benzisothiazolinone-13C5 | 1329616-16-1 | - | |
Benzisothiazolinone-13C5 (1,2-Benzothiazol-3-one-13C5) is a 13C-labeled Benzisothiazolinone. | ||||
